Features of humoral immunity in patients with mild traumatic brain injury

Cover Page

Cite item

Full Text

Abstract

Traumatic brain injury (TBI) is an important problem of the healthcare system. A lPeading role in pathogenesis belongs to the action of shock wave upon skull and brain integuments, extending from the impacted site, as well as displacement and rotation of the cerebral hemispheres relative to the fixed brain stem. As a result, a cascade of metabolic, biochemical and inflammatory changes is initiated, leading to secondary damage. TBI, depending on its mechanism, severity and type, causes various primary structural and functional brain lesions at molecular, cellular, tissue and organ levels with dysregulation of all systems in the body, dependent on its degree and extent. In most cases, the brain injury increases the risk of developing epilepsy and neurodegenerative diseases such as Alzheimer’s disease, arkinson’s disease and chronic traumatic encephalopathy (CTE), with mental health disorders. TBI is a long-term symptomatic process in patients with functional and structural damage. In response to a traumatic event, the damage-associated molecular patterns (DAMPs) encountered upon tissue damage are expressed, which cause activation of the resident brain tissue cells, and secretion of multiple chemokine and cytokine by distinct cell populations. Neutrophils migrate to focal lesions, which remove damaged cells and debris. Migration of T and B cells is observed 3-7 days after the trauma. Hence, following primary injury, due to a cascade of immune reactions, a more extensive lesion, the so-called secondary trauma, is developed. The aim of our study was to evaluate the role of immune response in pathogenesis of mild traumatic brain injury.

An increased number of Bm2 cells, IgDdimCD27low “naive” B cells and B cells with the IgDlowCD27hi (“plasmablasts”) phenotype was found in patients with mild brain contusion, compared to comparison group. Moreover, the number of “naive” mature B cells with the CD27lowCD38dim phenotype was significantly decreased compared with the controls.

About the authors

Anna O. Norka

First St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology

Author for correspondence.
Email: norka-anna@mail.ru

Senior Laboratory Assistant, Department of Immunology; Neurologist, Medical Centre

Russian Federation, St. Petersburg; St. Petersburg

S. V. Vorobyev

V. Almazov National Medical Research Centre

Email: norka-anna@mail.ru

PhD, MD (Medicine), Chief Research Associate, Research Laboratory of Neurology and Neurorehabilitation

Russian Federation, St. Petersburg

R. N. Kuznetsova

First St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology

Email: norka-anna@mail.ru

PhD (Medicine), Associate Professor, Department of Immunology; Allergist-Immunologist, Medical Centre

Russian Federation, St. Petersburg; St. Petersburg

M. K. Serebriakova

Institute of Experimental Medicine

Email: norka-anna@mail.ru

Postgraduate Student, Research Associate, Department of Immunology

Russian Federation, St. Petersburg

I. V. Kudryavtsev

First St. Petersburg State I. Pavlov Medical University; Institute of Experimental Medicine

Email: norka-anna@mail.ru

PhD (Biology), Senior Research Associate, Department of Immunology; Associate Professor, Department of Immunology

Russian Federation, St. Petersburg; St. Petersburg

S. N. Kovalenko

S. Kirov Military Medical Academy

Email: norka-anna@mail.ru

Lecturer, Department of Neurosurgery

Russian Federation, St. Petersburg

D. N. Monashenko

St. Petersburg City Hospital No. 26

Email: norka-anna@mail.ru

PhD (Medicine), Neurosurgeon

Russian Federation, St. Petersburg

Z. R. Korobova

First St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology

Email: norka-anna@mail.ru

Laboratory Researcher, Laboratory of Molecular Immunology; Senior Laboratory Assistant, Department of Immunology

Russian Federation, St. Petersburg; St. Petersburg

References

  1. Кудрявцев И.В., Субботовская А.И. Опыт измерения параметров иммунного статуса с использованием шестицветного цитофлуоримерического анализа // Медицинская иммунология, 2015. T. 17, № 1. С. 19-26. [Kudryavtsev I.V., Subbotovskaya A.I. Application of six-color flow cytometric analysis for immune profile monitoring. Meditsinskaya immunologiya = Medical Immunology (Russia), 2015, Vol. 17, no. 1, pp. 19-26. (In Russ.)] doi: 10.15789/1563-0625-2015-1-19-26.
  2. Лихтерман Л.Б. Черепно-мозговая травма. Диагностика и лечение. М.: ГЭОТАР-Медиа, 2014. 488 с. [Lichterman L.B. Traumatic brain injury. Diagnosis and treatment]. Moscow: GEOTAR-Media, 2014. 488 p.
  3. Потапов А.А., Лихтерман Л.Б., Кравчук А.Д., Корниенко В.Н., Захарова Н.Е., Ошоров А.В., Филатов М.М. Современные подходы к изучению и лечению черепно-мозговой травмы // Анналы клинической и экспериментальной неврологии, 2010. Т. 4, № 1. С. 4-12. [Potapov A.A., Likhterman L.B., Kravchuk A.D., Kornienko V.N., Zakharova N.E., Oshorov A.V., Filatova M.M. Modern approaches to the management of traumatic brain injury. Annaly klinicheskoy i eksperimentalnoy nevrologii = Annals of Clinical and Experimental Neurology, 2010, Vol. 4, no. 1, pp. 4-12. (In Russ.)]
  4. Хайдуков С.В., Байдун Л.А., Зурочка А.В., Тотолян Арег А., Хайдуков С.В. Стандартизованная технология «исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (проект) // Медицинская иммунология, 2012. Т. 14, № 3. С. 255-268. [Khaydukov S.V, Baidun L.A., Zurochka A.V., Totolyan Areg A. Standardized technology “Study of the subpopulation composition of peripheral blood lymphocytes using flow cytofluorometer-analyzers” (project). Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, Vol. 14, no. 3, pp. 255-268. (In Russ.)] doi: 10.15789/1563-0625-2012-3-255-268.
  5. Dantzer R., O’Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci., 2008, Vol. 9, no. 1, pp. 46-56.
  6. McKee C.A., Lukens J.R. Emerging roles for the immune system in traumatic brain injury. Front. Immunol., 2016, Vol. 7, 556. doi: 10.3389/fimmu.2016.00556.
  7. Nizamutdinov D., Shapiro L.A. Overview of traumatic brain injury: an immunological context. Brain Sci., 2017, Vol. 7, no. 1, 11. doi: 10.3390/brainsci7010011.
  8. Prak E.T.L., Ross J., Sutter J., Sullivan K.E. Age-related trends in pediatric B-cell subsets. Pediatr. Dev. Pathol., 2011, Vol. 14, no. 1, pp. 45-52.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Norka A.O., Vorobyev S.V., Kuznetsova R.N., Serebriakova M.K., Kudryavtsev I.V., Kovalenko S.N., Monashenko D.N., Korobova Z.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies